ImmunityBio(DE:26CA)
€5.46-0.18 (-3.19%)
DE:26CA
ImmunityBio hedge funds
€5.46
At close:-0.18 (-3.19%)
ImmunityBio (26CA) Hedge Fund Trading Activity
19 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 575.0K Shares Last Quarter
Hedge Fund Holdings in 26CA
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
 Kenneth Tropin | Graham Capital Management, L.P. | New | 100.00% | $83,423 | <0.01% | ||
 Michael Rockefeller | Woodline Partners LP | Reduced | -34.94% | $6,824,149 | 0.03% | ||
 Stephen A. Schwarzman | Blackstone Inc. | Sold Out | -100.00% | $23,649 | 0.00% |
FAQ
Which hedge funds hold ImmunityBio?
The hedge funds that hold the most shares in ImmunityBio are Michael Rockefeller, Kenneth Tropin and Stephen A. Schwarzman.
Are hedge funds buying or selling DE:26CA?
In the last quarter hedge funds have Decreased their holdings in ImmunityBio by 575.0K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in ImmunityBio stock?
Warren Buffet currently does not own shares in ImmunityBio.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
